DfnsHQ is thrilled to announce a successful funding round, raising an impressive $16 million to further enhance its Wallets-as-a-Service (WaaS) offerings. Dfns is at the forefront of digital asset management, providing state-of-the-art wallet APIs that empower fintechs, institutions, and enterprises globally to simplify their crypto operations securely. Our innovative solutions, including Wallet Entitlement Management (WEM) and Key Deployment Service (KDS), enable clients to efficiently manage workflows and multiple keys from a single platform, ensuring compliance with global security standards. With the news of this new funding, Dfns aims to expand its capabilities, streamline operations for developers, and enhance security protocols to cater to the growing needs of the financial sector. Our API-first approach has made us the preferred platform for renowned names such as ABN AMRO, Fidelity, and Stripe, solidifying our place as a trusted multichain wallet backend. To date, we have successfully created over 10 million wallets, facilitating $5 billion in transactions without any security breaches or loss of keys. This latest funding round brings our total capital raised to $28 million, with contributions from esteemed investors like White Star Capital, Coinbase, and Bpifrance. As we move forward, our commitment remains unwavering — to provide the highest level of security and innovation in digital asset management, further solidifying our reputation as a leader in the industry.

dfnsHQ Secures $16M in Series A Funding to Revolutionize Digital Asset Management
Get the full dfnsHQ company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Alitheon
Alitheon provides the last solution you will need for identification, authentication, and traceability of parts and products with our fail-proof, simple-to-use FeaturePrint system. FeaturePrint is an advanced machine-vision technology that provides for items, what fingerprints are for people – a unique and persistent identifier for the one in millions. FeaturePrint serializes items. As such, it enables track & trace, eliminates counterfeits and gray markets, and reduces human error ....all with just a photo using a standard camera. No bar codes, No QR codes, No stickers, No tags, No 'invisible' dust, No markers, No holograms, No special cameras, No special lighting, No Nonsense!
$8.0M Series a
today

The Ryl Company™
The Ryl Company™ is The Modern Tea Company — where nostalgic taste, clean ingredients, and functional benefits come together. Our flagship brand, Ryl Tea, reimagines the classic tea experience with zero sugar, 5 calories or less, nothing artificial, and antioxidant-powered functionality. We believe better-for-you should taste like the flavors you grew up loving. That’s why we exist: to help people Rethink Your Liquids (RYL). Available nationwide.
$20.0M Series c
today

Tavo Biotherapeutics
Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology. TAV-001 engages two novel targets that represent fundamental mechanisms underlying the pathology of glaucoma-related neurodegeneration. In pre-clinical studies, TAV-001 has shown signals of neuroprotection as well as substantial reduction in intraocular pressure, suggesting that it could represent the first disease-modifying pharmaceutical therapy for these patients. TAV-001 is expected to enter a Phase 1 clinical trial in glaucoma patients in 2025. TAV-002 represents a potential first-in-class treatment for retinal disease, including diabetic retinopathy, diabetic macular edema, and both wet and dry age-related macular degeneration. Tavo has initiated IND-enabling activities for this program.
$17.0M Series a
today

Adaptive Innovations Corp
Adaptive Innovations is an engineering firm and system integrator specializing in the design, fabrication, integration, and installation of custom equipment, automation & robotic solutions, tooling, fixtures, and gages. Comprised of a diverse group of professional engineers with backgrounds in design, controls, manufacturing, and electrical engineering disciplines, our outstanding team can help position your company to compete in today’s global economy. Combining industry best designs with exceptional process knowledge, fed by cross-industry exposure, Adaptive sets itself apart from its competition through every step of a project. We have a history of consistently delivering cost effective solutions, an excellent on-time delivery record, and unparalleled customer service, making Adaptive the engineering partner you can count on. Adaptive is considered the market leader in the design and fabrication of environmental test fixtures for testing such as HALT/HASS, ESS, and ED vibration or combined environments. We have experience with a wide array of automated solutions, including, assembly, pick-n-place, adhesive dispense, soldering, sorting, inspection etc. We're a Fanuc approved integrator, and have also integrated robots from ABB, Epson, Denso, and Adept. Our controls engineers are familiar with Beckhoff, Allen Bradley, Fanuc, Siemens, Mitsubishi, and National Instruments, contrllers and have a wide range of experience with robotic applications.
$50.0M Series a
today

Mia Health
Mia Health provides accurate risk assessments of large groups or populations which is crucial for the efficiency and resource optimization of health systems. With our customizable rapid screening and risk stratification platform you can now scale health systems significantly for more efficient and cost-effective population health management. Mia Health enables anyone to rapidly screen and stratify patient risk profiles using data collected through a smartphone in just 60 seconds. By measuring key vitals and providing critical insights to inform clinical or systemic decision-making, Mia Health simultaneously enables patient recommendations once a clinical decision has been made. Our proprietary cognitive AI encodes the expertise of dozens of world leading physicians making the Mia Health platform the most informed health stratification tool in the world and the only one of its kind. This eagerly anticipated and desperately needed technology is drastically closing the gap on delivering accessible, equitable care to all those who need it regardless of geographic location, economic status, race or gender. Learn More: https://www.miahealth.io
$920.0K Seed
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Alitheon United States | Series a | $8.0M | today |
| 2 | ![]() Tavo Biotherapeutics | Series a | $17.0M | today |
| 3 | ![]() Adaptive Innovations Corp United States | Series a | $50.0M | today |
| 4 | ![]() Novellia United States | Series a | $18.0M | today |
| 5 | ![]() GenerativeX United States | Series a | $650.0M | today |

